References
- Sokol L, Loughran T P, Jr. Large granular lymphocyte leukemia. Oncologist 2006; 11: 263–273
- O'Malley D P. T-cell large granular leukaemia and related proliferations. Am J Clin Pathol 2007; 127: 850–859
- Lamy T, Loughran T P, Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev 1999; 13: 230–240
- Pandolfi F, Loughran T P, Jr, Starkebaum G, Chisesi T, Barbui T, Chan W C, et al. Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study. Cancer 1990; 65: 341–348
- Lamy T, Loughran T P. Large granular lymphocyte leukemia. Cancer Control 1998; 5: 25–33
- Johnson S A. Fludarabine is an effective agent in non-Hodgkin's lymphoma and in combination therapy for acute myeloid leukaemia. Hematol J 2005; 5(Suppl 1)50–61
- Borthacur G, O'Brien S, Wiendo W G, Thomas W G, Thomas D A, Cortes J E, et al. Immune anemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab. Incidence and predictors. Br J Haematol 2007; 136: 800–805
- Sternberg A, Eagleton H, Pillai N, Leydec K, Turner S, Pearson D, et al. Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia respond to fludarabine with minimal toxicity. Br J Haematol 2003; 120: 699–701
- Aribi A, Huh Y, Keating M, O'Brien S, Ferrajoli A, Faderi S, et al. T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years. Leuk Res 2007; 31: 939–945
- Ma S Y, Au W Y, Chim C S, Lie A K, Lam C C, Tse E, et al. Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients. Br J Haematol 2004; 124: 754–761
- Sternberg A, Eagleton H, Pillai N, Leyden K, Turner S, Pearson D, et al. Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity. Br J Haematol 2003; 120: 699–701